Annalise.ai has introduced the world's first radiology triage device designed to detect and notify healthcare professionals about obstructive hydrocephalus (OHCP) in non-contrast brain CT scans.
This innovative technology employs advanced algorithms to assist radiologists in efficiently prioritizing non-contrast head CT studies when critical findings related to OHCP are suspected. Moreover, it streamlines radiology workflows and significantly enhances the speed of diagnosis and treatment.
This recently approved algorithm bolsters the presence in the United States, now offering a total of ten FDA-cleared findings. These encompass five for chest X-rays (CXR) and five for head CT scans (CTB), solidifying its position as a prominent provider of one of the most comprehensive FDA-cleared AI triage solutions in the country.
Obstructive hydrocephalus is a potentially life-threatening medical condition characterized by the accumulation of cerebrospinal fluid within the cranial vault. This buildup results in elevated intracranial pressure, which can escalate rapidly if not promptly diagnosed and treated.
This groundbreaking technology significantly contributes to the early detection and management of OHCP, ultimately improving patient outcomes and saving lives.